United Therapeutics Analyst Ratings
BenzingaMar 7 07:25 ET
United Therapeutics Analyst Ratings
BenzingaFeb 12 05:14 ET
United Therapeutics Analyst Ratings
BenzingaFeb 5 07:13 ET
Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $314
BenzingaNov 2, 2023 15:19 ET
United Therapeutics Analyst Ratings
BenzingaNov 2, 2023 15:19 ET
United Therapeutics Analyst Ratings
BenzingaNov 2, 2023 09:13 ET
United Therapeutics (UTHR) Receives a Buy From Wedbush
TipRanksAug 18, 2023 10:35 ET
Ladenburg Thalmann Maintains Buy on United Therapeutics, Raises Price Target to $268
BenzingaAug 3, 2023 09:28 ET
Wedbush Lifts United Therapeutics' Price Target to $307 From $305 After 'Strong' Q2 Results, Keeps Outperform Rating
MT NewswiresAug 3, 2023 07:04 ET
United Therapeutics Analyst Ratings
BenzingaAug 3, 2023 06:27 ET
The Latest Analyst Ratings for United Therapeutics
BenzingaMay 4, 2023 14:04 ET
Ladenburg Thalmann Adjusts Price Target on United Therapeutics to $256 From $285, Maintains Buy Rating
MT NewswiresMay 4, 2023 10:18 ET
Ladenburg Thalmann Maintains Buy on United Therapeutics, Lowers Price Target to $256
BenzingaMay 4, 2023 07:45 ET
H.C. Wainwright Sticks to Its Buy Rating for United Therapeutics (UTHR)
TipRanksMay 4, 2023 06:37 ET
Argus Research Maintains Buy on United Therapeutics, Lowers Price Target to $280
BenzingaApr 21, 2023 09:23 ET
UBS Trims Price Target on United Therapeutics to $310 From $330, Keeps Buy Rating
MT NewswiresApr 10, 2023 10:33 ET
Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $316
BenzingaApr 10, 2023 10:27 ET
Credit Suisse Lowers United Therapeutics' Price Target to $290 From $293, Maintains Outperform Rating
MT NewswiresMar 20, 2023 09:27 ET
Morgan Stanley Maintains Overweight on United Therapeutics, Lowers Price Target to $320
BenzingaFeb 23, 2023 08:41 ET
Wedbush Sticks to Their Buy Rating for United Therapeutics (UTHR)
TipRanksFeb 23, 2023 07:18 ET
No Data
No Data